Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Johnson and Johnson
AstraZeneca
Healthtrust
Merck
Daiichi Sankyo
Queensland Health
QuintilesIMS
Cipla

Generated: January 19, 2018

DrugPatentWatch Database Preview

CLARITIN HIVES RELIEF REDITAB Drug Profile

« Back to Dashboard

Which patents cover Claritin Hives Relief Reditab, and what generic alternatives are available?

Claritin Hives Relief Reditab is a drug marketed by Bayer Healthcare Llc and is included in one NDA.

The generic ingredient in CLARITIN HIVES RELIEF REDITAB is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and thirty-six suppliers are listed for this compound. Additional details are available on the loratadine profile page.
Drug patent expirations by year for CLARITIN HIVES RELIEF REDITAB
Medical Subject Heading (MeSH) Categories for CLARITIN HIVES RELIEF REDITAB

US Patents and Regulatory Information for CLARITIN HIVES RELIEF REDITAB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Healthcare Llc CLARITIN HIVES RELIEF REDITAB loratadine TABLET, ORALLY DISINTEGRATING;ORAL 020704-003 Nov 19, 2003 OTC Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
Express Scripts
Federal Trade Commission
Boehringer Ingelheim
Accenture
Colorcon
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot